ARCHIVES

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

Cooperative Group Chairmen Unhappy Over Contracts They Missed, NCI Protocol Review

January 13, 1978

Paul Okunieff Named Director At UF Shands Cancer Center

October 16, 2009

No Protective Effect From Long-Term Vitamin E or C

November 28, 2008

Inspector General’s chronology Of Events In Gallo Research

July 1, 1994

HHS, NIH Prepare for Government Shutdown

September 20, 2013

In Brief: Broder Wins ARC’s Griffuel Prize; Lawyers Trained To Help Low-Income Breast Ca, Patients

October 16, 1992